Results for Fanconi Anemia

1 - 5 of 5

Dr. Tong investigates cytokine receptor signaling in normal and neoplastic hematopoietic development. She uses integrated approaches encompassing biochemistry, molecular biology, mouse models, and primary human samples to understand signaling events emanating from cytokine receptors that regulate the development of hematopoietic stem/progenitor cells.

E-mail:

tongw [at] email.chop.edu

View Wei Tong's Profile

Peter Kurre, MD

Dr. Kurre's laboratory has longstanding expertise in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications. With training in transplantation and hematopoietic stem cell biology, he hopes to improve the understanding of the progressive hematopoietic failure in patients with bone marrow failure and FA, broaden diagnostic approaches, and develop next generation therapies.

E-mail:

kurrep [at] email.chop.edu

View Peter Kurre's Profile

Comprehensive Bone Marrow Failure Center

Bringing together physicians and researchers to provide state-of-the-art diagnostics, clinical care, and investigational studies as well as basic research focused on acquired and inherited bone marrow failure.

Kurre Laboratory

The Kurre Laboratory has a longstanding interest in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications. With expertise in transplantation and hematopoietic stem cell biology, the lab aims to improve the understanding of the progressive hematopoietic failure in patients with BMF and FA, broaden diagnostic approaches, and develop next generation therapies.

Targeting Abnormal Signals Suggests Novel Method to Treat a Rare Childhood Blood Disease

Published on

Oct 9, 2018

in Press Releases

In Animal Study, CHOP Hematologist Restores Blood Cell Function in Fanconi Anemia